Skip to main content
Call
CARC 55 · CO-55

CARC 55 Denial: Procedure/treatment/drug is deemed experimental/investigational by the payer — How to Fix and Appeal

Reviewed by QuickIntell RCM Editorial Team · Last reviewed

Updated

TL;DR

CARC 55 (X12 Procedure/treatment/drug is deemed experimental/investigational by the payer). CARC 55 indicates the payer's medical policy classifies the service as experimental or investigational and therefore non-covered.

Official X12 description

“Procedure/treatment/drug is deemed experimental/investigational by the payer.”

Source: X12 Claim Adjustment Reason Codes. The X12 External Code Lists are the single authoritative source for every CARC descriptor — always verify against the current release before building a claim-scrub rule.

What CARC 55 actually means

CARC 55 indicates the payer's medical policy classifies the service as experimental or investigational and therefore non-covered. These are the hardest denials to overturn — success rests on peer-reviewed literature, specialty-society guidelines, and sometimes appeals to an Independent Medical Review. Many cases require a predetermination letter before the service or a formal appeal with strong clinical support.

Common root causes

  • Specific CPT/HCPCS/drug on the payer's E&I exclusion list.
  • Indication billed is outside the FDA-approved or evidence-supported use.

Prevention checklist

  • Predetermination or prior-authorization request for any high-cost service on the payer's E&I list.
  • Patient-consent and financial-responsibility documentation executed before the service when payer coverage is uncertain.

Appeal strategy — step by step

Most CARC 55 denials clear faster with the right remediation than with a formal appeal. Work the steps in order and escalate only when a lower-effort path has been ruled out.

  1. 1Submit a medical-necessity appeal with peer-reviewed literature, specialty-society guidelines, and clinical context for this patient.
  2. 2Escalate to external/independent review when the plan has exhausted internal appeals.
Sample appeal-letter language for CARC 55
[Provider letterhead] Re: Appeal of CARC 55 — Claim #{claim_number} Member: {member_name} · Member ID: {member_id} Date(s) of Service: {dos} On {remittance_date} this claim was adjusted with CARC 55: "Procedure/treatment/drug is deemed experimental/investigational by the payer." We respectfully request reconsideration. The X12 External Code List definition of CARC 55 does not apply to this claim for the following reasons: 1. [Cite the clinical / coding / policy fact that rebuts the adjustment] 2. [Cite the supporting documentation attached — op note, EOB, LCD/NCD citation, NCCI edit indicator, modifier rationale] 3. [Cite the payer's own policy where applicable] Attached: {list supporting documents} Please process payment under the member's benefits. If additional information is required, contact the billing office at {provider_phone} or {provider_email}. Sincerely, {billing_manager_name}, {credentials}

Edit the bracketed fields before sending. This template is a starting point; a payer-specific appeal form may still be required — check the provider portal first.

Payer-specific notes

Payer-specific behavior for CARC 55 publishes here as the QuickIntell anonymized denial ETL ingests sufficient volume. In the meantime, consult the payer directory for the relevant provider manual and appeal form.

How common is CARC 55?

Search demand rank
#31

Out of 306 seeded CARCs, ranked by combined US monthly search volume for "CARC 55", "CO-55 denial", and "denial code 55".

Platform frequency
Pending ETL

Platform frequency ranks publish once the anonymized denial-rate pipeline reaches the publication threshold (strategy §12 Phase 2).

How QuickRCM prevents CARC 55

QuickRCM catches the root causes above before the 837 leaves the clearinghouse:

  • Claim-scrub rules fire on every root cause listed above — the scrub references the same X12 CAS segment logic that drives the denial, so what the payer checks, QuickRCM checks first.
  • When a denial lands, QuickRCM routes it to the correct worker with the documentation bundle already attached (op note, LCD citation, modifier rationale, EOB, primary 835).
  • Appeal templates tuned to each CARC (including this one) pull the supporting facts from the claim and fill the bracketed fields automatically.
See QuickRCM →Book a demo

Frequently asked questions — CARC 55

What does CARC 55 mean?

CARC 55 is an X12 Claim Adjustment Reason Code. The official definition is: "Procedure/treatment/drug is deemed experimental/investigational by the payer." In plain English, the payer is telling you cARC 55 indicates the payer's medical policy classifies the service as experimental or investigational and therefore non-covered. These are the hardest denials to overturn — success rests on peer-reviewed literature, specialty-society guidelines, and sometimes appeals to an Independent Medical Review. Many cases require a predetermination letter before the service or a formal appeal with strong clinical support.

How do I resolve a CARC 55 (CO-55) denial?

Start with the most common root cause: Specific CPT/HCPCS/drug on the payer's E&I exclusion list. First step: Submit a medical-necessity appeal with peer-reviewed literature, specialty-society guidelines, and clinical context for this patient. See the full remediation and appeal checklist on this page before filing a formal appeal.

Is CARC 55 patient responsibility?

No — CARC 55 is typically carried under CO (Contractual Obligation) or OA (Other Adjustment), which means it is the provider's responsibility, not the patient's. Do not bill the patient unless the 835 CAS group code is PR.

What does CARC 55 look like on an EOB or 835 remittance?

On the 835 ERA, CARC 55 appears in Loop 2110 CAS segment as "CAS*CO*55*{amount}". On a paper EOB the same code prints in the Adjustment/Denial Reason column with the X12 description: "Procedure/treatment/drug is deemed experimental/investigational by the payer." — usually paired with one or more RARC remark codes in the same remittance line for additional context.

Which RARC is paired with CARC 55?

CARC 55 is commonly observed with RARC N115, N130, N386. The RARC narrows the reason — for example, pointing at a missing modifier, an LCD citation, or a specific policy. Fix the underlying CARC first; the RARC usually clears with the corrected claim.

Disclaimer

This page is operational reference for medical-billing professionals. It is not legal, clinical, or contractual advice. X12 code descriptors are maintained by the X12 External Code Lists; always verify against the current X12 release and the payer's own published policy before submitting or appealing a claim.